| Older periods | Dec '19 | Mar '20 | Jun '20 | Sep '20 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.33 | 0.13 | 0.17 | 0.09 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(4.18) | (0.69) | (1.39) | (0.71) | |
P/B ratio |
0.29 | 0.03 | 0.04 | 0.02 | |
Price to Tangible BV |
0.29 | 0.03 | 0.04 | 0.02 | |
EV/Sales |
18.01 | 15.51 | 18.40 | 9.92 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(61.61) | (40.15) | (44.85) | (12.01) | |
EV/FCF |
(40.46) | (32.40) | (36.37) | (11.15) | |
Quick Ratio |
4.16 | 3.99 | 4.46 | 0.20 | |
Current Ratio |
5.18 | 4.89 | 5.53 | 0.26 | |
Net Debt/EBITDA |
(3.09) | (356.95) | (28.09) | (60.54) | |
Debt/Assets |
47.58% | 49.97% | 52.72% | 53.38% | |
Debt/Equity |
1.00 | 1.12 | 1.24 | 1.32 | |
Asset Turnover |
0.09 | 0.10 | 0.09 | 0.09 | |
Operating CF/Net income |
0.24 | 0.77 | 0.30 | 0.36 | |
Capex/Depreciation |
(0.15) | (0.19) | (0.04) | (0.08) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.70% | 10.78% | 27.90% | 18.28% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
6.02% | 2.07% | 4.64% | 2.99% | |
Graham Net Nets |
(2.60) | (25.79) | (24.34) | (51.94) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(181.86%) | (1,653.49%) | (1,487.76%) | (2,920.83%) | |
Free Cash Flow Yield |
(33.42%) | (375.13%) | (296.27%) | (1,024.85%) | |
Revenue per Share |
0.44 | 1.19 | 0.52 | 0.62 | |
Operating CF per Share |
(0.98) | (0.62) | (0.35) | (0.34) | |
Capex per Share |
(0.05) | (0.08) | (0.01) | (0.03) | |
Free Cash Flow per Share |
(1.03) | (0.70) | (0.37) | (0.37) | |
Cash per Share |
3.80 | 3.73 | 3.36 | 2.99 | |
Shareholders Equity per Share |
14.25 | 13.43 | 12.29 | 11.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.25 | 13.43 | 12.29 | 11.37 | |
Free Cash Flow |
(77.15) | (52.68) | (27.51) | (27.63) | |
Working Capital |
315.17 | 337.20 | 283.62 | (904.04) | |
Capital Expenditures |
(4.00) | (5.92) | (1.05) | (2.37) | |
Net Current Asset Value |
(797.14) | (833.69) | (896.86) | (937.47) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.12 | 0.07 | 0.03 | 0.05 | |
Net Profit Margin |
(930.00%) | (68.17%) | (224.62%) | (151.34%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
48.90 | 70.26 | 60.24 | 26.96 | |
Average Payables |
19.58 | 18.54 | 18.44 | 14.26 | |
Average Inventory |
42.18 | 43.09 | 43.77 | 44.60 | |
Average Assets |
2,502.39 | 2,476.59 | 2,388.61 | 2,328.45 | |
Average Common Equity |
1,343.89 | 1,272.58 | 1,193.82 | 1,114.85 |
Columns are period end dates